Physician Survey on Monitoring of Patients Treated With Quetiapine
NCT01795326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2014-01-28
Summary
A physician survey to document receipt of metabolic educational materials and assess behavior of physicians in following messages communicated through the educational materials
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Robert S Brody, MPH · AZ
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2013-09-30
- Completion
- 2013-09-30
More Related Trials
-
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
NCT01256177 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel in Bipolar Depression Versus SSRI
NCT00119652 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder
NCT00227305 ·Status: COMPLETED ·Phase: PHASE3
-
A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
NCT03403790 ·Status: COMPLETED
-
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
NCT00060489 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate Bipolar Maintenance Monotherapy
NCT00314184 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
NCT00320268 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
NCT00422214 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
NCT00278941 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders
NCT00252226 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
NCT00326144 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
NCT00926393 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
NCT00351169 ·Status: COMPLETED ·Phase: PHASE3
-
Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
NCT03872596 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder
NCT00107731 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
NCT00321490 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 /Seroquel SR Acute Mania Monotherapy - US
NCT00422123 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
NCT00329264 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder.
NCT00521365 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
NCT00085891 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
NCT00329446 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
NCT00883493 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison
NCT00702676 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Quetiapine on Ultrastructural Hippocampal and Neurochemical Changes in Patients With Bipolar Disorder: Searching for Antidepressant and Mood Stabilising Neurophysiology
NCT01552837 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers
NCT01908296 ·Status: COMPLETED ·Phase: PHASE1